Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Jan 19;169(1):47–57. doi: 10.1007/s10549-017-4649-y

Fig. 5.

Fig. 5

Efatutazone regulates the expression of genes associated with lipid accumulation in MCFDCIS xenograft tumors. qRT-PCR analysis of a human and b mouse FABP4, PLIN2, and PDK4 mRNA levels in MCFDCIS tumor tissues treated 3 weeks with vehicle or 30 mg/kg efatutazone. Mean ± SEM (Student’s t test; n = 10; *p < 0.05 vs vehicle; ***p < 0.001 vs vehicle)